HD-OPM Archive
Topics › Insulin resistance & diabetes

Shulman: liver and muscle fat directly cause insulin resistance, even in lean people

Louis Nervegna · Oct 20, 2025 · ♥ 6 reactions · 0 comments · original Facebook post
Insulin resistance & diabetesWeight, visceral & liver fat
↻ This is a repost. The main version (highest ranked) is Gerald Shulman honored for showing how ectopic fat causes insulin resistance · Aug 03, 2025.
AI summary & key facts

Louis shares a Yale announcement of Gerald Shulman's 2023 EASD-Lilly Centennial Anniversary Prize. Shulman discovered the molecular mechanisms by which ectopic fat in liver and muscle cause insulin resistance, which explains susceptibility in lean individuals and why weight loss and GLP-1 agonists reverse insulin resistance and type 2 diabetes.

(no text — see the shared post below)

Research cited

Gerald Shulman is recognized for discovering the molecular mechanisms by which ectopic fat accumulation in the liver and muscle directly cause insulin resistance.

His work has revolutionized the biological understanding of what causes diabetes.

(It explains why fat accumulation in liver and muscle causes insulin resistance even in lean individuals.)

From the Yale School of Medicine

Quoted:

“Gerald I. Shulman, MD, PhD, George R. Cowgill Professor of Medicine (Endocrinology) and professor of cellular and molecular physiology, and co-director of the Yale Diabetes Research Center, received the 2023 European Association for the Study of Diabetes (EASD)-Lilly Centennial Anniversary Prize. The award recognizes individual researchers who have made landmark achievements in the pathogenesis of diabetes.”

“As part of his award, Shulman will give a lecture titled “The Role of Ectopic Lipid in Insulin Resistance and Cardiometabolic Disease” at the EASD annual meeting, in Hamburg, Germany, on October 6, 2023.

Over the past three decades, Shulman has been studying the molecular basis for insulin resistance.”

Quoted:

“This mechanism by which ectopic lipid in liver and muscle promotes insulin resistance explains why even lean individuals can be susceptible to insulin resistance and cardiometamolic disease and how weight loss and agents that promote weight loss, such as the new class of GLP-1 agonists, reverse insulin resistance and type 2 diabetes,” Shulman said.

Shulman’s work has led to several paradigm shifts in the understanding of type 2 diabetes, as well as the development of new therapeutics that reduce excess ectopic lipid in the liver and muscle by promoting increase fat oxidation in these organs.

“Given our new understanding of the molecular basis of insulin resistance and the new drugs in development to target this mechanism, I’m very optimistic about the future of treating insulin resistance and cardiometabolic disease to promote metabolic health,” Shulman said.

#geraldshulmanHD #yaleHD #insulinresistanceHD #liverfatHD #musclefatHD #weightlossHD #diabetesHD #roytaylorHD #liverfatsummaryHD

← newer: Liver fat above 1.85% is linked with insulin resistance, farolder: Diabetes researchers cite fat in muscle and liver as the mai →